BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 21441901)

  • 1. AURKA and BRCA2 expression highly correlate with prognosis of endometrioid ovarian carcinoma.
    Yang F; Guo X; Yang G; Rosen DG; Liu J
    Mod Pathol; 2011 Jun; 24(6):836-45. PubMed ID: 21441901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2.
    Yang G; Chang B; Yang F; Guo X; Cai KQ; Xiao XS; Wang H; Sen S; Hung MC; Mills GB; Chang S; Multani AS; Mercado-Uribe I; Liu J
    Clin Cancer Res; 2010 Jun; 16(12):3171-81. PubMed ID: 20423983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival.
    DeRycke MS; Andersen JD; Harrington KM; Pambuccian SE; Kalloger SE; Boylan KL; Argenta PA; Skubitz AP
    Am J Clin Pathol; 2009 Dec; 132(6):846-56. PubMed ID: 19926575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of targeting drug-based molecular biomarkers expression in ovarian clear cell carcinoma].
    Li MJ; Li HR; Cheng X; Bi R; Tu XY; Liu F; Chen LH
    Zhonghua Fu Chan Ke Za Zhi; 2017 Dec; 52(12):835-843. PubMed ID: 29325268
    [No Abstract]   [Full Text] [Related]  

  • 5. DEF6 expression in ovarian carcinoma correlates with poor patient survival.
    Liew PL; Fang CY; Lee YC; Lee YC; Chen CL; Chu JS
    Diagn Pathol; 2016 Aug; 11(1):68. PubMed ID: 27488395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors.
    Lim D; Murali R; Murray MP; Veras E; Park KJ; Soslow RA
    Am J Surg Pathol; 2016 Mar; 40(3):302-12. PubMed ID: 26551621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTNNB1 Mutations and Aberrant β-Catenin Expression in Ovarian Endometrioid Carcinoma: Correlation With Patient Outcome.
    Zyla RE; Olkhov-Mitsel E; Amemiya Y; Bassiouny D; Seth A; Djordjevic B; Nofech-Mozes S; Parra-Herran C
    Am J Surg Pathol; 2021 Jan; 45(1):68-76. PubMed ID: 32769429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low membranous expression of beta-catenin and high mitotic count predict poor prognosis in endometrioid carcinoma of the ovary.
    Rosen DG; Zhang Z; Chang B; Wang X; Lin E; Liu J
    Mod Pathol; 2010 Jan; 23(1):113-22. PubMed ID: 19820688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis.
    Barreta A; Sarian LO; Ferracini AC; Costa LBE; Mazzola PG; de Angelo Andrade L; Derchain S
    Hum Pathol; 2019 Mar; 85():72-81. PubMed ID: 30447298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAS promotes tumorigenesis through genomic instability induced by imbalanced expression of Aurora-A and BRCA2 in midbody during cytokinesis.
    Yang G; Mercado-Uribe I; Multani AS; Sen S; Shih IeM; Wong KK; Gershenson DM; Liu J
    Int J Cancer; 2013 Jul; 133(2):275-85. PubMed ID: 23319376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma.
    Borgoño CA; Fracchioli S; Yousef GM; Rigault de la Longrais IA; Luo LY; Soosaipillai A; Puopolo M; Grass L; Scorilas A; Diamandis EP; Katsaros D
    Int J Cancer; 2003 Sep; 106(4):605-610. PubMed ID: 12845660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor-binding protein 2 and 5 are differentially regulated in ovarian cancer of different histologic types.
    Wang H; Rosen DG; Wang H; Fuller GN; Zhang W; Liu J
    Mod Pathol; 2006 Sep; 19(9):1149-56. PubMed ID: 16729015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synchronous endometrial and ovarian carcinomas: predictors of risk and associations with survival and tumor expression profiles.
    Kelemen LE; Rambau PF; Koziak JM; Steed H; Köbel M
    Cancer Causes Control; 2017 May; 28(5):447-457. PubMed ID: 28194593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer.
    Choschzick M; Oosterwijk E; Müller V; Woelber L; Simon R; Moch H; Tennstedt P
    Virchows Arch; 2011 Aug; 459(2):193-200. PubMed ID: 21691815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of aurora kinase A is associated with metastasis-free survival in node-negative breast cancer patients.
    Siggelkow W; Boehm D; Gebhard S; Battista M; Sicking I; Lebrecht A; Solbach C; Hellwig B; Rahnenführer J; Koelbl H; Gehrmann M; Marchan R; Cadenas C; Hengstler JG; Schmidt M
    BMC Cancer; 2012 Nov; 12():562. PubMed ID: 23186136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L1CAM expression associates with poor outcome in endometrioid, but not in clear cell ovarian carcinoma.
    Soovares P; Pasanen A; Bützow R; Lassus H
    Gynecol Oncol; 2017 Sep; 146(3):615-622. PubMed ID: 28625395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients.
    Mignogna C; Staropoli N; Botta C; De Marco C; Rizzuto A; Morelli M; Di Cello A; Franco R; Camastra C; Presta I; Malara N; Salvino A; Tassone P; Tagliaferri P; Barni T; Donato G; Di Vito A
    J Ovarian Res; 2016 May; 9(1):31. PubMed ID: 27209210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
    [No Abstract]   [Full Text] [Related]  

  • 19. Aurora-A expression is independently associated with chromosomal instability in colorectal cancer.
    Baba Y; Nosho K; Shima K; Irahara N; Kure S; Toyoda S; Kirkner GJ; Goel A; Fuchs CS; Ogino S
    Neoplasia; 2009 May; 11(5):418-25. PubMed ID: 19412426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative serum 8-hydroxydeoxyguanosine is associated with chemoresistance and is a powerful prognostic factor in endometrioid-type epithelial ovarian cancer.
    Pylväs-Eerola M; Karihtala P; Puistola U
    BMC Cancer; 2015 Jul; 15():493. PubMed ID: 26134400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.